News
RGC
7.46
+10.36%
0.70
Regencell Bioscience Holdings (RGC) Looks Pricey On DOJ Probe And Internal Control Concerns
Simply Wall St · 1d ago
Weekly Report: what happened at RGC last week (1019-1023)?
Weekly Report · 1d ago
Weekly Report: what happened at RGC last week (1012-1016)?
Weekly Report · 10/19 09:36
Regencell Bioscience rises 11.7%
TipRanks · 10/15 16:06
Regencell Bioscience rises 8.4%
TipRanks · 10/14 14:00
Regencell Bioscience rises 9.0%
TipRanks · 10/13 16:06
Weekly Report: what happened at RGC last week (1005-1009)?
Weekly Report · 10/12 09:39
Regencell Bioscience rises 9.1%
TipRanks · 10/08 16:05
Weekly Report: what happened at RGC last week (0928-1002)?
Weekly Report · 10/05 09:38
Weekly Report: what happened at RGC last week (0921-0925)?
Weekly Report · 09/28 09:36
Regencell Bioscience: I Got It Wrong (Rating Downgrade)
Seeking Alpha · 09/23 10:36
Weekly Report: what happened at RGC last week (0914-0918)?
Weekly Report · 09/21 09:36
Weekly Report: what happened at RGC last week (0907-0911)?
Weekly Report · 09/14 09:39
Weekly Report: what happened at RGC last week (0831-0904)?
Weekly Report · 09/07 09:36
Weekly Report: what happened at RGC last week (0824-0828)?
Weekly Report · 08/31 09:39
Weekly Report: what happened at RGC last week (0817-0821)?
Weekly Report · 08/24 09:39
Weekly Report: what happened at RGC last week (0810-0814)?
Weekly Report · 08/17 09:40
Weekly Report: what happened at RGC last week (0803-0807)?
Weekly Report · 08/10 09:37
Weekly Report: what happened at RGC last week (0727-0731)?
Weekly Report · 08/03 09:37
Weekly Report: what happened at RGC last week (0720-0724)?
Weekly Report · 07/27 09:39
More
Webull provides a variety of real-time RGC stock news. You can receive the latest news about Regencell Bioscience Holdings Ltd through multiple platforms. This information may help you make smarter investment decisions.
About RGC
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.